{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T01:56:34Z","timestamp":1744509394101,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":23,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493972210"},{"type":"electronic","value":"9781493972234"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7223-4_16","type":"book-chapter","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T11:54:40Z","timestamp":1502452480000},"page":"213-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Eduardo G.","family":"Cafferata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Veronica","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe J.","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A. R.","family":"Maenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo L.","family":"Podhajcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,12]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1089\/hum.1998.9.11-1617","volume":"9","author":"R Martiniello-Wilks","year":"1998","unstructured":"Martiniello-Wilks R, Garcia-Aragon J, Daja MM, Russell P, Both GW, Molloy PL, Lockett LJ, Russell PJ (1998) In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors. Hum Gene Ther 9:1617\u20131626","journal-title":"Hum Gene Ther"},{"doi-asserted-by":"crossref","unstructured":"Onimaru M, Ohuchida K, Mizumoto K, Nagai E, Cui L, Toma H, Takayama K, Matsumoto K, Hashizume M, Tanaka M (2010) hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells. Cancer Sci 101:735\u2013742","key":"16_CR2","DOI":"10.1111\/j.1349-7006.2009.01445.x"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-08-1161","volume":"15","author":"EG Cafferata","year":"2009","unstructured":"Cafferata EG, Maccio DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL (2009) A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clin Cancer Res 15:3037\u20133049","journal-title":"Clin Cancer Res"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.gt.3300823","volume":"6","author":"G Cao","year":"1999","unstructured":"Cao G, Kuriyama S, Gao J, Kikukawa M, Cui L, Nakatani T, Zhang X, Tsujinoue H, Pan X, Fukui H et al (1999) Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. Gene Ther 6:83\u201390","journal-title":"Gene Ther"},{"key":"16_CR5","first-page":"5258","volume":"54","author":"T Osaki","year":"1994","unstructured":"Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T (1994) Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54:5258\u20135261","journal-title":"Cancer Res"},{"doi-asserted-by":"crossref","unstructured":"Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL (1997) The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 108:210\u2013214","key":"16_CR6","DOI":"10.1111\/1523-1747.ep12334263"},{"doi-asserted-by":"crossref","unstructured":"Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92:679\u2013690","key":"16_CR7","DOI":"10.1002\/jcb.20091"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/mt.2012.147","volume":"20","author":"MV Lopez","year":"2012","unstructured":"Lopez MV, Rivera AA, Viale DL, Benedetti L, Cuneo N, Kimball KJ, Wang M, Douglas JT, Zhu ZB, Bravo AI et al (2012) A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice. Mol Ther 20:2222\u20132233","journal-title":"Mol Ther"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1535-7163.647.3.5","volume":"3","author":"G Powis","year":"2004","unstructured":"Powis G, Kirkpatrick L (2004) Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 3:647\u2013654","journal-title":"Mol Cancer Ther"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1172\/JCI119069","volume":"98","author":"Y Cao","year":"1996","unstructured":"Cao Y, Linden P, Shima D, Browne F, Folkman J (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor\/vascular endothelial growth factor. J Clin Invest 98:2507\u20132511","journal-title":"J Clin Invest"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1099\/vir.0.82603-0","volume":"88","author":"J Adriaansen","year":"2007","unstructured":"Adriaansen J, Fallaux FJ, de Cortie CJ, Vervoordeldonk MJ, Tak PP (2007) Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats. J Gen Virol 88:1717\u20131721","journal-title":"J Gen Virol"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Van Antwerp","year":"1996","unstructured":"Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787\u2013789","journal-title":"Science"},{"doi-asserted-by":"crossref","unstructured":"Blagodatski A, Poteryaev D, Katanaev VL (2014) Targeting the Wnt pathways for therapies. Mol Cell Ther 2:28","key":"16_CR13","DOI":"10.1186\/2052-8426-2-28"},{"doi-asserted-by":"crossref","unstructured":"Song L, Li ZY, Liu WP, Zhao MR (2015) Crosstalk between Wnt\/beta-catenin and Hedgehog\/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biol Ther 16:1\u20137","key":"16_CR14","DOI":"10.4161\/15384047.2014.972215"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.tig.2010.08.003","volume":"26","author":"L Bai","year":"2010","unstructured":"Bai L, Morozov AV (2010) Gene regulation by nucleosome positioning. Trends Genet 26:476\u2013483","journal-title":"Trends Genet"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1101\/gr.6101007","volume":"17","author":"HE Peckham","year":"2007","unstructured":"Peckham HE, Thurman RE, Fu Y, Stamatoyannopoulos JA, Noble WS, Struhl K, Weng Z (2007) Nucleosome positioning signals in genomic DNA. Genome Res 17:1170\u20131177","journal-title":"Genome Res"},{"issue":"4","key":"16_CR17","doi-asserted-by":"publisher","first-page":"e5119","DOI":"10.1371\/journal.pone.0005119","volume":"4","author":"M. Ver\u00f3nica Lopez","year":"2009","unstructured":"Lopez MV, Viale DL, Cafferata EG, Bravo AI, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL (2009) Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses. PLoS One 4:e5119","journal-title":"PLoS ONE"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","volume":"7","author":"FJ Fallaux","year":"1996","unstructured":"Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7:215\u2013222","journal-title":"Hum Gene Ther"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jgm.1053","volume":"9","author":"M Khoury","year":"2007","unstructured":"Khoury M, Adriaansen J, Vervoordeldonk MJ, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D, Tak PP, Jorgensen C et al (2007) Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med 9:596\u2013604","journal-title":"J Gene Med"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00109-011-0826-3","volume":"90","author":"MC Subang","year":"2012","unstructured":"Subang MC, Fatah R, Bright C, Blanco P, Berenstein M, Wu Y, Podhajcer OL, Winyard PG, Chernajovsky Y, Gould D (2012) A novel hybrid promoter responsive to pathophysiological and pharmacological regulation. J Mol Med (Berl) 90:401\u2013411","journal-title":"J Mol Med (Berl)"},{"issue":"44","key":"16_CR21","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1021\/bi0013896","volume":"39","author":"Jos\u00e9 Guti\u00e9rrez","year":"2000","unstructured":"Gutierrez J, Sierra J, Medina R, Puchi M, Imschenetzky M, van Wijnen A, Lian J, Stein G, Stein J, Montecino M (2000) Interaction of CBF alpha\/AML\/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site. Biochemistry 39:13565\u201313574","journal-title":"Biochemistry"},{"issue":"5","key":"16_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nprot.2007.135","volume":"2","author":"Jinyong Luo","year":"2007","unstructured":"Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW et al (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236\u20131247","journal-title":"Nature Protocols"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/1566523013348689","volume":"1","author":"B Breyer","year":"2001","unstructured":"Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, He TC (2001) Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1:149\u2013162","journal-title":"Curr Gene Ther"}],"container-title":["Methods in Molecular Biology","Mammalian Synthetic Promoters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7223-4_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:49:07Z","timestamp":1662166147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-7223-4_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493972210","9781493972234"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7223-4_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"12 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}